[Study of the action of a coronary dilator agent: (isoamyloxy-3 (trimethoxy-3,4,5 benzoyloxy)-propyl)-4 tetrahydro-oxazine-1,4 hydrochloride (amoproxan) on the metabolism of adenylic derivatives].
D000205:Actomyosin / Q000378:metabolism; D000241:Adenosine / Q000378:metabolism*; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000262:Adenylyl Cyclases / Q000378:metabolism; D000619:Aminohydrolases / Q000378:metabolism; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004386:Duodenum / Q000201:enzymology; D004573:Electrolytes / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D004987:Ethers / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D009025:Morpholines / Q000494:pharmacology*; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009708:Nucleotidases / Q000378:metabolism; D010042:Ouabain / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology*
D001565:Benzoates; D004573:Electrolytes; D004987:Ethers; D009025:Morpholines; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D010042:Ouabain; D000255:Adenosine Triphosphate; D000205:Actomyosin; D010208:Papaverine; D000242:Cyclic AMP; D009708:Nucleotidases; D000619:Aminohydrolases; D000251:Adenosine Triphosphatases; D000262:Adenylyl Cyclases; D000241:Adenosine
Etude de l'action d'un coronarodilatateur: le chlorhydrate d'(isoamyloxy-3 (trimethoxy-3,4,5 benzoyloxy)-propyl)-4 tétrahydro-oxazine-1,4 (amoproxan) sur le métabolisme de dérivés adényliques.